ABSTRACT
Background Large language models (LLMs) pretrained on vast amounts of data have significantly influenced recent advances in artificial intelligence. While GPT-4 has demonstrated high performance in general medical examinations, its performance in specialised areas such as nephrology is unclear. This study aimed to compare ChatGPT and Bard and their potential clinical applications in nephrology.
Methods Ninety-nine questions from the Self-Assessment Questions for Nephrology Board Renewal from 2018 to 2022 were presented to two versions of ChatGPT (GPT-3.5 and GPT-4) and Bard. We calculated the overall correct answer rates for the five years, each year, and question categories and checked whether they exceeded the pass criterion. The correct answer rates were compared with those of the nephrology residents.
Results The overall correct answer rates for GPT-3.5, GPT-4, and Bard were 31.3% (31/99), 54.5% (54/99), and 32.3% (32/99), respectively, thus GPT-4 demonstrated significantly higher performance than GPT-3.5 (p < 0.01) and Bard (p < 0.01). GPT-4 met the passing criteria in three years. GPT-4 demonstrated significantly higher performance in problem-solving, clinical, and non-image questions than GPT-3.5 and Bard. The correct answer rate for GPT-4 was intermediate between the rates for third- and fourth-year nephrology residents.
Conclusions GPT-4 significantly outperformed GPT-3.5 and Bard and met the Nephrology Board renewal standards in three of five years. These findings underline the potential applications of LLMs in nephrology as well as their advantages and disadvantages. As LLMs advance, nephrologists must understand their performance and reliability for future applications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has not been supported by any grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Due to the proprietary nature of the data used for this study (Self-Assessment Questions for Nephrology Board Renewal), the authors cannot post the raw data used for the analysis. However, the authors are able to share a part of the collected data (ex. large language model responses, etc.) on request to other researchers who have access to this exam.